| 1 |
|
[^1^1C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy/
|
Gerhard, A
|
Advanstar Communications [etc.]
|
2003
|
|
|
|
| 2 |
|
(123I)b-CIT SPECT imaging assessment of the rate of Parkinson's disease progression/
|
Marek, K
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 3 |
|
14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: A prospective study in 112 patients/
|
Lemstra, A W
|
Advanstar Communications [etc.]
|
2000
|
|
|
|
| 4 |
|
1 Hz rTMS enhances extrastriate cortex activity in migraine: Evidence of a reduced inhibition?/
|
Fierro, B
|
Advanstar Communications [etc.]
|
2003
|
|
|
|
| 5 |
|
53rd Meeting Program Overview/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 6 |
|
5-year risk of MS after optic neuritis: Experience of the Optic Neuritis Treatment Trial - Optic Neuritis Study Group/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 7 |
|
A 1-year controlled trial of acetyl-L-carnitine in early-onset AD/
|
Thal, L J
|
Advanstar Communications [etc.]
|
2000
|
|
|
|
| 8 |
|
A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients/
|
Mohs, R C
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 9 |
|
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD/
|
Winblad, B
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 10 |
|
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease/
|
Feldman, H
|
Advanstar Communications [etc.]
|
2001
|
|
|
|